Form 4 for ALKS Alkermes plc.
Accepted 2026-06-01 19:26:49 ET · period of report 2026-06-01 · accession 0001520262-26-000097 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DT | 2026-06-01 19:26 | 2026-06-01 | ALKS | Hopkinson Craig C. | EVP R, D, Chief Medical Off | M - OptEx | $19.34 | +5,000 | 86.4K | +6% | +$96.7K |
| DT | 2026-06-01 19:26 | 2026-06-01 | ALKS | Hopkinson Craig C. | EVP R, D, Chief Medical Off | S - Sale+OE | $41.67 | -9,000 | 77.4K | -10% | -$375.0K |
| DT | 2026-06-01 19:26 | 2026-06-01 | ALKS | Hopkinson Craig C. | EVP R, D, Chief Medical Off | M - OptEx | $0.00 | -5,000 | 6,356 | -44% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Ordinary Shares | 2026-06-01 | M | A | 5,000 | $19.34 | 86,389 | D | — | — | (F1) This option exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 3/14/2025. |
| 2 | Common | Ordinary Shares | 2026-06-01 | S | D | 9,000 | $41.67 | 77,389 | D | — | — | (F2) This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 3/14/2025. (F3) The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $41.37 to $42.19. Full information regarding the number of shares sold at each separate price can be provided to the issuer, any security holder of the issuer or the SEC staff upon request. |
| 3 | Derivative | Employee Stock Option (Right to Buy) | 2026-06-01 | M | D | 5,000 | $0.00 | 6,356 | D | $19.34 · — to 2031-02-22 | 5,000 Ordinary Shares | (F1) This option exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 3/14/2025. (F4) These options are fully vested in accordance with their terms. |